C M Hull
Affiliation: University of Utah
- Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trialC Hull
Department of Dermatology, University of Utah, Salt Lake City, UT, USA
J Eur Acad Dermatol Venereol 23:263-7. 2009..The dual role of immune responses (protection, pathology) is well recognized in other infectious diseases. The addition of corticosteroids to antimicrobial agents has been associated with improvement in some of these diseases...
- Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformisC M Hull
Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA
Br J Dermatol 159:120-4. 2008..More recently, antibodies directed at epidermal transglutaminase (TG3) were identified in patients with DH, and this may be the dominant autoantigen in this disease...
- Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trialChristopher M Hull
Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132 2409, USA
J Am Acad Dermatol 64:696.e1-11. 2011..ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL...
- The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialisChristopher M Hull
Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA
Postgrad Med 122:1-6. 2010....